newsfilter
← Latest News
Business Wire·

BML, One of Sesen Bio's Top Stockholders, Announces Support for Pending Merger with Carisma Therapeutics

Sesen Bio Board Unanimously Recommends All Stockholders to Vote "FOR" the Value Maximizing Merger on the WHITE Proxy Card Today Sesen Bio, Inc. (NASDAQ:SESN) ("Sesen Bio" or the "Company"), today announced that BML